3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
4
Head and Neck Neoplasms
4
Cancer Pain
3
Agnosia
3
Prostatic Neoplasms
2
Breast Neoplasms
2
Xerostomia
1
Uterine Cervical Neoplasms
1
Urinary Retention
1
Thyroid Neoplasms
1
Tendinopathy
1
Stomatitis
1
Radiculopathy
1
Pancreatic Neoplasms
1
Pain, Procedural
1
Pain, Postoperative
1
Osteoarthritis, Knee
1
Oropharyngeal Neoplasms
1
Nociceptive Pain
1
Neuralgia, Postherpetic
1
Neuralgia
1
Neoplasms
1
Neck Pain
1
Nasopharyngeal Carcinoma
1
Mouth Neoplasms
1
Mobility Limitation
1
Lymphoma, Follicular
1
Lymphedema
1
Lower Urinary Tract Symptoms
1
Liver Neoplasms
1
Interventions
Morphine
7
Ketamine
5
Fentanyl
4
Sodium Chloride
3
Saline Solution
3
Lidocaine
3
Educational Status
3
Dexmedetomidine
3
Cognitive Behavioral Therapy
3
Anesthetics, Local
3
Surveys and Questionnaires
2
Pregabalin
2
Mindfulness-Based Stress Reduction
2
Hypnosis
2
Bupivacaine
2
Botulinum Toxins, Type A
2
Acetaminophen
2
6'-fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro(cyclohexane-1,1'(3'H)-pyrano(3,4-b)indol)-4-amine
2
tianeptine
1
siltuximab
1
onabotulinum toxin A
1
nabiximols
1
morphine, naltrexone combination
1
erenumab
1
Yoga
1
Waiting Lists
1
Transcutaneous Electric Nerve Stimulation
1
Tramadol
1
Therapeutics
1
Telemedicine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Chronic Pain
×
Transcutaneous Electric Nerve Stimulation
×
Clear all
NCT01944150
2017-08-03
HYPTENS
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
72 enrolled